Wheeze study for young children
Part of Immune system & allergy, Infections clinical trials.
This study looks at young children (ages 1-5) who have had severe wheezing episodes that needed hospital care. It aims to find biomarkers (clues in the body) that could help predict which children might develop asthma later.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 1 and 5 years old.
- Your child must have had at least 2 hospital stays for wheezing in the past year, or at least 1 stay that required a high dependency unit or IV breathing treatments.
- Your child must not have another lung condition like cystic fibrosis or bronchiectasis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at different kinds of wheezing in young children (ages 1 to 5) to better understand what causes it and how to treat it. If your child has had wheezing more than once, this research could help find patterns that lead to better care.
This study looks at how the gut and lungs affect breathing problems in children. It compares samples from children with and without respiratory illnesses to understand why some children get sicker than others.
This study supports children ages 2–6 who have been diagnosed with preschool wheeze and need regular lung follow-up. It checks a “next step” approach for managing symptoms in children who already use inhaler medicine and have had recent wheezing episodes.
This study follows children and teens who are being checked for asthma for the first time. It aims to learn more about the early symptoms of asthma to improve diagnosis and treatment.
This study tests if giving oral steroids (medicine to reduce airway swelling) only when needed based on a child's own biology can help preschool children with wheezing. It aims to find the best treatment for each child, avoiding unnecessary medicine.
This study tests if the medicine Dupilumab can help control asthma and wheezing in children ages 2 to just under 6. It is for children whose symptoms are not well-managed with their current inhaler.
Hear when a new Wheezing trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.